Showing posts with label diabetes. Show all posts
Showing posts with label diabetes. Show all posts

Thursday, November 21, 2024

The megafat could be the healthiest


Typically obesity leads to health problems via insulin resistance (). Excess calories are stored as fat in fat cells up to a certain point. Beyond this point fat cells start rejecting fat. This is the point where fat cells become insulin resistant.

When they become insulin resistant, fat cells no longer respond to the insulin-mediated signal that they should store fat. Fat then increases in circulation and starts getting stored in tissues other than fat cells, including organ tissues (visceral fat). When the organ in question is the liver, this is called non-alcoholic fatty liver disease.

This progression happens with most people, but not with those who can progress to extremely high body fat levels (). Those people are the “megafat-prone” (MP). In the MP, fat cells take a long time to start rejecting fat. So the MP can keep on gaining body fat, often with no sign of diabetes at body fat levels that would have caused serious harm to most people.

One could say that the MP are extremely metabolically resilient. By not becoming insulin resistance as they gain more and more body fat, the MP are somewhat similar to sumo wrestlers (photo below from Nationalgeographic.com); although the main reason why sumo wrestlers do not develop insulin resistance is vigorous exercise. Visceral fat is very easy to "mobilize" through vigorous exercise; this being the basis for the "fat-but-fit" phenomenon (). There are two interesting, and also speculative, inferences that can be made based on all of this.



One is that the MP could potentially be the healthiest people among us. This is due to their extreme metabolic resilience, which should be fairly protective if they can avoid getting up to the unhealthy point of body fat for them. In fact, they could be overweight or even obese and fairly healthy, at least in terms of degenerative diseases. This is a genetic predisposition, which is likely to run in families.

The other inference is that the MP would probably not look “ripped” at relatively low weights. Since their body fat cells have above average insulin sensitivity at high body fat levels, one would expect that high insulin sensitivity to remain at low body fat levels. Insulin sensitivity is strongly associated with longevity ().

So, bringing all of this together, here are two apparent paradoxes. That person who already gained a lot of body fat and is an MP, showing no health problems at or near obesity, could be the healthiest among us. And that person who cannot look ripped at low body fat levels, no matter how hard he or she tries, may be one of the 2 percent or so of the population who will live beyond 90.

Unfortunately it is hard to tell whether someone is MP or not until the person actually becomes megafat. And if you are MP and actually become megafat, the afterlife will very likely arrive sooner rather than later.

Tuesday, June 22, 2021

Blood glucose control before age 55 may increase your chances of living beyond 90

This post refers to an interesting study by Yashin and colleagues (2009) at Duke University’s Center for Population Health and Aging. (The full reference to the article, and a link, are at the end of this post.) This study is a gem with some rough edges, and some interesting implications.

The study uses data from the Framingham Heart Study (FHS). The FHS, which started in the late 1940s, recruited 5209 healthy participants (2336 males and 2873 females), aged 28 to 62, in the town of Framingham, Massachusetts. At the time of Yashin and colleagues’ article publication, there were 993 surviving participants.

I rearranged figure 2 from the Yashin and colleagues article so that the two graphs (for females and males) appeared one beside the other. The result is shown below (click on it to enlarge); the caption at the bottom-right corner refers to both graphs. The figure shows the age-related trajectory of blood glucose levels, grouped by lifespan (LS), starting at age 40.


As you can see from the figure above, blood glucose levels increase with age, even for long-lived individuals (LS > 90). The increases follow a U-curve (a.k.a. J-curve) pattern; the beginning of the right side of a U curve, to be more precise. The main difference in the trajectories of the blood glucose levels is that as lifespan increases, so does the width of the U curve. In other words, in long-lived people, blood glucose increases slowly with age; particularly up to 55 years of age, when it starts increasing more rapidly.

Now, here is one of the rough edges of this study. The authors do not provide standard deviations. You can ignore the error bars around the points on the graph; they are not standard deviations. They are standard errors, which are much lower than the corresponding standard deviations. Standard errors are calculated by dividing the standard deviations by the square root of the sample sizes for each trajectory point (which the authors do not provide either), so they go up with age since progressively smaller numbers of individuals reach advanced ages.

So, no need to worry if your blood glucose levels are higher than those shown on the vertical axes of the graphs. (I will comment more on those numbers below.) Not everybody who lived beyond 90 had a blood glucose of around 80 mg/dl at age 40. I wouldn't be surprised if about 2/3 of the long-lived participants had blood glucose levels in the range of 65 to 95 at that age.

Here is another rough edge. It is pretty clear that the authors’ main independent variable (i.e., health predictor) in this study is average blood glucose, which they refer to simply as “blood glucose”. However, the measure of blood glucose in the FHS is a very rough estimation of average blood glucose, because they measured blood glucose levels at random times during the day. These measurements, when averaged, are closer to fasting blood glucose levels than to average blood glucose levels.

A more reliable measure of average blood glucose levels is that of glycated hemoglobin (HbA1c). Blood glucose glycates (i.e., sticks to, like most sugary substances) hemoglobin, a protein found in red blood cells. Since red blood cells are relatively long-lived, with a turnover of about 3 months, HbA1c (given in percentages) is a good indicator of average blood glucose levels (if you don’t suffer from anemia or a few other blood abnormalities). Based on HbA1c, one can then estimate his or her average blood glucose level for the previous 3 months before the test, using one of the following equations, depending on whether the measurement is in mg/dl or mmol/l.

    Average blood glucose (mg/dl) = 28.7 × HbA1c − 46.7

    Average blood glucose (mmol/l) = 1.59 × HbA1c − 2.59

The table below, from Wikipedia, shows average blood glucose levels corresponding to various HbA1c values. As you can see, they are generally higher than the corresponding fasting blood glucose levels would normally be (the latter is what the values on the vertical axes of the graphs above from Yashin and colleagues’ study roughly measure). This is to be expected, because blood glucose levels vary a lot during the day, and are often transitorily high in response to food intake and fluctuations in various hormones. Growth hormone, cortisol and noradrenaline are examples of hormones that increase blood glucose. Only one hormone effectively decreases blood glucose levels, insulin, by stimulating glucose uptake and storage as glycogen and fat.


Nevertheless, one can reasonably expect fasting blood glucose levels to have been highly correlated with average blood glucose levels in the sample. So, in my opinion, the graphs above showing age-related blood glucose trajectories are still valid, in terms of their overall shape, but the values on the vertical axes should have been measured differently, perhaps using the formulas above.

Ironically, those who achieve low average blood glucose levels (measured based on HbA1c) by adopting a low carbohydrate diet (one of the most effective ways) frequently have somewhat high fasting blood glucose levels because of physiological (or benign) insulin resistance. Their body is primed to burn fat for energy, not glucose. Thus when growth hormone levels spike in the morning, so do blood glucose levels, as muscle cells are in glucose rejection mode. This is a benign version of the dawn effect (a.k.a. dawn phenomenon), which happens with quite a few low carbohydrate dieters, particularly with those who are deep in ketosis at dawn.

Yashin and colleagues also modeled relative risk of death based on blood glucose levels, using a fairly sophisticated mathematical model that takes into consideration U-curve relationships. What they found is intuitively appealing, and is illustrated by the two graphs at the bottom of the figure below. The graphs show how the relative risks (e.g., 1.05, on the topmost dashed line on the both graphs) associated with various ranges of blood glucose levels vary with age, for both females and males.


What the graphs above are telling us is that once you reach old age, controlling for blood sugar levels is not as effective as doing it earlier, because you are more likely to die from what the authors refer to as “other causes”. For example, at the age of 90, having a blood glucose of 150 mg/dl (corrected for the measurement problem noted earlier, this would be perhaps 165 mg/dl, from HbA1c values) is likely to increase your risk of death by only 5 percent. The graphs account for the facts that: (a) blood glucose levels naturally increase with age, and (b) fewer people survive as age progresses. So having that level of blood glucose at age 60 would significantly increase relative risk of death at that age; this is not shown on the graph, but can be inferred.

Here is a final rough edge of this study. From what I could gather from the underlying equations, the relative risks shown above do not account for the effect of high blood glucose levels earlier in life on relative risk of death later in life. This is a problem, even though it does not completely invalidate the conclusion above. As noted by several people (including Gary Taubes in his book Good Calories, Bad Calories), many of the diseases associated with high blood sugar levels (e.g., cancer) often take as much as 20 years of high blood sugar levels to develop. So the relative risks shown above underestimate the effect of high blood glucose levels earlier in life.

Do the long-lived participants have some natural protection against accelerated increases in blood sugar levels, or was it their diet and lifestyle that protected them? This question cannot be answered based on the study.

Assuming that their diet and lifestyle protected them, it is reasonable to argue that: (a) if you start controlling your average blood sugar levels well before you reach the age of 55, you may significantly increase your chances of living beyond the age of 90; (b) it is likely that your blood glucose levels will go up with age, but if you can manage to slow down that progression, you will increase your chances of living a longer and healthier life; (c) you should focus your control on reliable measures of average blood glucose levels, such as HbA1c, not fasting blood glucose levels (postprandial glucose levels are also a good option, because they contribute a lot to HbA1c increases); and (d) it is never too late to start controlling your blood glucose levels, but the more you wait, the bigger is the risk.

References:

Taubes, G. (2007). Good calories, bad calories: Challenging the conventional wisdom on diet, weight control, and disease. New York, NY: Alfred A. Knopf.

Yashin, A.I., Ukraintseva, S.V., Arbeev, K.G., Akushevich, I., Arbeeva, L.S., & Kulminski, A.M. (2009). Maintaining physiological state for exceptional survival: What is the normal level of blood glucose and does it change with age? Mechanisms of Ageing and Development, 130(9), 611-618.

Monday, October 21, 2019

Lipotoxicity or tired pancreas? Abnormal fat metabolism as a possible precondition for type 2 diabetes

The term “diabetes” is used to describe a wide range of diseases of glucose metabolism; diseases with a wide range of causes. The diseases include type 1 and type 2 diabetes, type 2 ketosis-prone diabetes (which I know exists thanks to Michael Barker’s blog), gestational diabetes, various MODY types, and various pancreatic disorders. The possible causes include genetic defects (or adaptations to very different past environments), autoimmune responses, exposure to environmental toxins, as well as viral and bacterial infections; in addition to obesity, and various other apparently unrelated factors, such as excessive growth hormone production.

Type 2 diabetes and the “tired pancreas” theory

Type 2 diabetes is the one most commonly associated with the metabolic syndrome, which is characterized by middle-age central obesity, and the “diseases of civilization” brought up by Neolithic inventions. Evidence is mounting that a Neolithic diet and lifestyle play a key role in the development of the metabolic syndrome. In terms of diet, major suspects are engineered foods rich in refined carbohydrates and refined sugars. In this context, one widely touted idea is that the constant insulin spikes caused by consumption of those foods lead the pancreas (figure below from Wikipedia) to get “tired” over time, losing its ability to produce insulin. The onset of insulin resistance mediates this effect.



Empirical evidence against the “tired pancreas” theory

This “tired pancreas” theory, which refers primarily to the insulin-secreting beta-cells in the pancreas, conflicts with a lot of empirical evidence. It is inconsistent with the existence of isolated semi/full hunter-gatherer groups (e.g., the Kitavans) that consume large amounts of natural (i.e., unrefined) foods rich in easily digestible carbohydrates from tubers and fruits, which cause insulin spikes. These groups are nevertheless generally free from type 2 diabetes. The “tired pancreas” theory conflicts with the existence of isolated groups in China and Japan (e.g., the Okinawans) whose diets also include a large proportion of natural foods rich in easily digestible carbohydrates, which cause insulin spikes. Yet these groups are generally free from type 2 diabetes.

Humboldt (1995), in his personal narrative of his journey to the “equinoctial regions of the new continent”, states on page 121 about the natives as a group that: "… between twenty and fifty years old, age is not indicated by wrinkling skin, white hair or body decrepitude [among natives]. When you enter a hut is hard to differentiate a father from son …" A large proportion of these natives’ diets included plenty of natural foods rich in easily digestible carbohydrates from tubers and fruits, which cause insulin spikes. Still, there was no sign of any condition that would suggest a prevalence of type 2 diabetes among them.

At this point it is important to note that the insulin spikes caused by natural carbohydrate-rich foods are much less pronounced than the ones caused by refined carbohydrate-rich foods. The reason is that there is a huge gap between the glycemic loads of natural and refined carbohydrate-rich foods, even though the glycemic indices may be quite similar in some cases. Natural carbohydrate-rich foods are not made mostly of carbohydrates. Even an Irish (or white) potato is 75 percent water.

More insulin may lead to abnormal fat metabolism in sedentary people

The more pronounced spikes may lead to abnormal fat metabolism because more body fat is force-stored than it would have been with the less pronounced spikes, and stored body fat is not released just as promptly as it should be to fuel muscle contractions and other metabolic processes. Typically this effect is a minor one on a daily basis, but adds up over time, leading to fairly unnatural patterns of fat metabolism in the long run. This is particularly true for those who lead sedentary lifestyles. As for obesity, nobody gets obese in one day. So the key problem with the more pronounced spikes may not be that the pancreas is getting “tired”, but that body fat metabolism is not normal, which in turn leads to abnormally high or low levels of important body fat-derived hormones (e.g., high levels of leptin and low levels of adiponectin).

One common characteristic of the groups mentioned above is absence of obesity, even though food is abundant and often physical activity is moderate to low. Repeat for emphasis: “… even though food is abundant and often physical activity is moderate to low”. Note that having low levels of activity is not the same as spending the whole day sitting down in a comfortable chair working on a computer. Obviously caloric intake and level of activity among these groups were/are not at the levels that would lead to obesity. How could that be possible? See this post for a possible explanation.

Excessive body fat gain, lipotoxicity, and type 2 diabetes

There are a few theories that implicate the interaction of abnormal fat metabolism with other factors (e.g., genetic factors) in the development of type 2 diabetes. Empirical evidence suggests that this is a reasonable direction of causality. One of these theories is the theory of lipotoxicity.

Several articles have discussed the theory of lipotoxicity. The article by Unger & Zhou (2001) is a widely cited one. The theory seems to be widely based on the comparative study of various genotypes found in rats. Nevertheless, there is mounting evidence suggesting that the underlying mechanisms may be similar in humans. In a nutshell, this theory proposes the following steps in the development of type 2 diabetes:

    (1) Abnormal fat mass gain leads to an abnormal increase in fat-derived hormones, of which leptin is singled out by the theory. Some people seem to be more susceptible than others in this respect, with lower triggering thresholds of fat mass gain. (What leads to exaggerated fat mass gains? The theory does not go into much detail here, but empirical evidence from other studies suggests that major culprits are refined grains and seeds, as well as refined sugars; other major culprits seem to be trans fats, and vegetable oils rich in linoleic acid.)

    (2) Resistance to fat-derived hormones sets in. Again, leptin resistance is singled out as the key here. (This is a bit simplistic. Other fat-derived hormones, like adiponectin, seem to clearly interact with leptin.) Since leptin regulates fatty acid metabolism, the theory argues, leptin resistance is hypothesized to impair fatty acid metabolism.

    (3) Impaired fat metabolism causes fatty acids to “spill over” to tissues other than fat cells, and also causes an abnormal increase in a substance called ceramide in those tissues. These include tissues in the pancreas that house beta-cells, which secrete insulin. In short, body fat should be stored in fat cells (adipocytes), not outside them.

    (4) Initially fatty acid “spill over” to beta-cells enlarges them and makes them become overactive, leading to excessive insulin production in response to carbohydrate-rich foods, and also to insulin resistance. This is the pre-diabetic phase where hypoglycemic episodes happen a few hours following the consumption of carbohydrate-rich foods. Once this stage is reached, several natural carbohydrate-rich foods also become a problem (e.g., potatoes and bananas), in addition to refined carbohydrate-rich foods.

    (5) Abnormal levels of ceramide induce beta-cell apoptosis in the pancreas. This is essentially “death by suicide” of beta cells in the pancreas. What follows is full-blown type 2 diabetes. Insulin production is impaired, leading to very elevated blood glucose levels following the consumption of carbohydrate-rich foods, even if they are unprocessed.

It is widely known that type 2 diabetics have impaired glucose metabolism. What is not so widely known is that usually they also have impaired fatty acid metabolism. For example, consumption of the same fatty meal is likely to lead to significantly more elevated triglyceride levels in type 2 diabetics than non-diabetics, after several hours. This is consistent with the notion that leptin resistance precedes type 2 diabetes, and inconsistent with the “tired pancreas” theory.

Weak and strong points of the theory of lipotoxicity

A weakness of the theory of lipotoxicity is its strong lipophobic tone; at least in the articles that I have read. There is ample evidence that eating a lot of the ultra-demonized saturated fat, per se, is not what makes people obese or type 2 diabetic. Yet overconsumption of trans fats and vegetable oils rich in linoleic acid does seem to be linked with obesity and type 2 diabetes. (So does the consumption of refined grains and seeds, and refined sugars.) The theory of lipotoxicity does not seem to make these distinctions.

In defense of the theory of lipotoxicity, it does not argue that there cannot be thin diabetics. Many type 1 diabetics are thin. Type 2 diabetics can also be thin, although this is much less common. In certain individuals, the threshold of body fat gain that will precipitate lipotoxicity may be quite low. In others, the same amount of body fat gain (or more) may in fact increase their insulin sensitivity under certain circumstances – e.g., when growth hormone levels are abnormally low.

Autoimmune disorders, perhaps induced by environmental toxins, or toxins found in certain refined foods, may cause the immune system to attack the beta-cells in the pancreas. This may lead to type 1 diabetes if all beta cells are destroyed, or something that can easily be diagnosed as type 2 (or type 1.5) diabetes if only a portion of the cells are destroyed, in a way that does not involve lipotoxicity.

Nor does the theory of lipotoxicity predict that all those who become obese will develop type 2 diabetes. It only suggests that the probability will go up, particularly if other factors are present (e.g., genetic propensity). There are many people who are obese during most of their adult lives and never develop type 2 diabetes. On the other hand, some groups, like Hispanics, tend to develop type 2 diabetes more easily (often even before they reach the obese level). One only has to visit the South Texas region near the Rio Grande border to see this first hand.

What the theory proposes is a new way of understanding the development of type 2 diabetes; a way that seems to make more sense than the “tired pancreas” theory. The theory of lipitoxicity may not be entirely correct. For example, there may be other mechanisms associated with abnormal fat metabolism and consumption of Neolithic foods that cause beta-cell “suicide”, and that have nothing to do with lipotoxicity as proposed by the theory. (At least one fat-derived hormone, tumor necrosis factor-alpha, is associated with abnormal cell apoptosis when abnormally elevated. Levels of this hormone go up immediately after a meal rich in refined carbohydrates.) But the link that it proposes between obesity and type 2 diabetes seems to be right on target.

Implications and thoughts

Some implications and thoughts based on the discussion above are the following. Some are extrapolations based on the discussion in this post combined with those in other posts. At the time of this writing, there were hundreds of posts on this blog, in addition to many comments stemming from over 2.5 million page views. See under "Labels" at the bottom-right area of this blog for a summary of topics addressed. It is hard to ignore things that were brought to light in previous posts.

    - Let us start with a big one: Avoiding natural carbohydrate-rich foods in the absence of compromised glucose metabolism is unnecessary. Those foods do not “tire” the pancreas significantly more than protein-rich foods do. While carbohydrates are not essential macronutrients, protein is. In the absence of carbohydrates, protein will be used by the body to produce glucose to supply the needs of the brain and red blood cells. Protein elicits an insulin response that is comparable to that of natural carbohydrate-rich foods on a gram-adjusted basis (but significantly lower than that of refined carbohydrate-rich foods, like doughnuts and bagels). Usually protein does not lead to a measurable glucose response because glucagon is secreted together with insulin in response to ingestion of protein, preventing hypoglycemia.

    - Abnormal fat gain should be used as a general measure of one’s likelihood of being “headed south” in terms of health. The “fitness” level for men and women shown on the table in this post seem like good targets for body fat percentage. The problem here, of course, is that this is not as easy as it sounds. Attempts at getting lean can lead to poor nutrition and/or starvation. These may make matters worse in some cases, leading to hormonal imbalances and uncontrollable hunger, which will eventually lead to obesity. Poor nutrition may also depress the immune system, making one susceptible to a viral or bacterial  infection that may end up leading to beta-cell destruction and diabetes. A better approach is to place emphasis on eating a variety of natural foods, which are nutritious and satiating, and avoiding refined ones, which are often addictive “empty calories”. Generally fat loss should be slow to be healthy and sustainable.

    - Finally, if glucose metabolism is compromised, one should avoid any foods in quantities that cause an abnormally elevated glucose or insulin response. All one needs is an inexpensive glucose meter to find out what those foods are. The following are indications of abnormally elevated glucose and insulin responses, respectively: an abnormally high glucose level 1 hour after a meal (postprandial hyperglycemia); and an abnormally low glucose level 2 to 4 hours after a meal (reactive hypoglycemia). What is abnormally high or low? Take a look at the peaks and troughs shown on the graph in this post; they should give you an idea. Some insulin resistant people using glucose meters will probably realize that they can still eat several natural carbohydrate-rich foods, but in small quantities, because those foods usually have a low glycemic load (even if their glycemic index is high).

Lucy was a vegetarian and Sapiens an omnivore. We apparently have not evolved to be pure carnivores, even though we can be if the circumstances require. But we absolutely have not evolved to eat many of the refined and industrialized foods available today, not even the ones marketed as “healthy”. Those foods do not make our pancreas “tired”. Among other things, they “mess up” fat metabolism, which may lead to type 2 diabetes through a complex process involving hormones secreted by body fat.

References

Humboldt, A.V. (1995). Personal narrative of a journey to the equinoctial regions of the new continent. New York, NY: Penguin Books.

Unger, R.H., & Zhou, Y.-T. (2001). Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes, 50(1), S118-S121.

Monday, August 26, 2019

How much alcohol is optimal? Maybe less than you think

I have been regularly recommending to users of the software HCE () to include a column in their health data reflecting their alcohol consumption. Why? Because I suspect that alcohol consumption is behind many of what we call the “diseases of affluence”.

A while ago I recall watching an interview with a centenarian, a very lucid woman. When asked about her “secret” to live a long life, she said that she added a little bit of whiskey to her coffee every morning. It was something like a tablespoon of whiskey, or about 15 g, which amounted to approximately 6 g of ethanol every single day.

Well, she might have been drinking very close to the optimal amount of alcohol per day for the average person, if the study reviewed in this post is correct.

Studies of the effect of alcohol consumption on health generally show results in terms of averages within fixed ranges of consumption. For example, they will show average mortality risks for people consuming 1, 2, 3 etc. drinks per day. These studies suggest that there is a J-curve relationship between alcohol consumption and health (). That is, drinking a little is better than not drinking; and drinking a lot is worse than drinking a little.

However, using “rough” ranges of 1, 2, 3 etc. drinks per day prevents those studies from getting to a more fine-grained picture of the beneficial effects of alcohol consumption.

Contrary to popular belief, the positive health effects of moderate alcohol consumption have little, if anything, to do with polyphenols such as resveratrol. Resveratrol, once believed to be the fountain of youth, is found in the skin of red grapes.

It is in fact the alcohol content that has positive effects, apparently reducing the incidence of coronary heart disease, diabetes, hypertension, congestive heart failure, stroke, dementia, Raynaud’s phenomenon, and all-cause mortality. Raynaud's phenomenon is associated with poor circulation in the extremities (e.g., toes, fingers), which in some cases can progress to gangrene.

In most studies of the effects of alcohol consumption on health, the J-curves emerge from visual inspection of the plots of averages across ranges of consumption. Rarely you find studies where nonlinear relationships are “discovered” by software tools such as WarpPLS (), with effects being adjusted accordingly.

You do find, however, some studies that fit reasonably justified functions to the data. Di Castelnuovo and colleagues’ study, published in JAMA Internal Medicine in 2006 (), is probably the most widely cited among these studies. This study is a meta-analysis; i.e., a study that builds on various other empirical studies.

I think that the journal in which this study appeared was formerly known as Archives of Internal Medicine, a fairly selective and prestigious journal, even though this did not seem to be reflected in its Wikipedia article at the time of this writing ().

What Di Castelnuovo and colleagues found is interesting. They fitted a bunch of nonlinear functions to the data, all with J-curve shapes. The results suggest a lot of variation in the maximum amount one can drink before mortality becomes higher than not drinking at all; that maximum amount ranges from about 4 to 6 drinks per day.

But there is little variation in one respect. The optimal amount of alcohol is somewhere around 5 and 7 g/d, which translates into about the following every day: half a can of beer, half a glass of wine, or half a “shot” of spirit. This is clearly a common trait of all of the nonlinear functions that they generated. This is illustrated in the figure below, from the article.



As you can seen from the curves above, a little bit of alcohol every day seems to have an acute effect on mortality reduction. And it seems that taking little doses every day is much better than taking the equivalent dose over a larger period of time; for instance, the equivalent per week, taken once a week. This is suggested by other studies as well ().

The curves above do not clearly reflect a couple of problems with alcohol consumption. One is that alcohol seems to be treated by the body as a toxin, which causes some harm and some good at the same time, the good being often ascribed to hormesis (). Someone who is more sensitive to alcohol’s harmful effects, on the liver for example, may not benefit as much from its positive effects.

The curves are averages that pass through points, after which the points are forgotten; even though they are real people.

The other problem with alcohol is that most people who are introduced to it in highly urbanized areas (where most people live) tend to drink it because of its mood-altering effects. This leads to a major danger of addiction and abuse. And drinking a lot of alcohol is much worse than not drinking at all.

Interestingly, in traditional Mediterranean Cultures where wine is consumed regularly, people tend to generally frown upon drunkenness ().

Wednesday, July 24, 2019

Ketosis, methylglyoxal, and accelerated aging: Probably more fiction than fact

This is a follow up on this post. Just to recap, an interesting hypothesis has been around for quite some time about a possible negative effect of ketosis. This hypothesis argues that ketosis leads to the production of an organic compound called methylglyoxal, which is believed to be a powerful agent in the formation of advanced glycation endproducts (AGEs).

In vitro research, and research with animals (e.g., mice and cows), indeed suggests negative short-term effects of increased ketosis-induced methylglyoxal production. These studies typically deal with what appears to be severe ketosis, not the mild type induced in healthy people by very low carbohydrate diets.

However, the bulk of methylglyoxal is produced via glycolysis, a multi-step metabolic process that uses sugar to produce the body’s main energy currency – adenosine triphosphate (ATP). Ketosis is a state whereby ketones are used as a source of energy instead of glucose.

(Ketones also provide an energy source that is distinct from lipoprotein-bound fatty acids and albumin-bound free fat acids. Those fatty acids appear to be preferred vehicles for the use of dietary or body fat as a source of energy. Yet it seems that small amounts of ketones are almost always present in the blood, even if they do not show up in the urine.)

Thus it follows that ketosis is associated with reduced glycolysis and, consequently, reduced methylglyoxal production, since the bulk of this substance (i.e., methylglyoxal) is produced through glycolysis.

So, how can one argue that ketosis is “a recipe for accelerated AGEing”?

One guess is that ketosis is being confused with ketoacidosis, a pathological condition in which the level of circulating ketones can be as much as 40 to 80 times that found in ketosis. De Grey (2007) refers to “diabetic patients” when he talks about this possibility (i.e., the connection with accelerated AGEing), and ketoacidosis is an unfortunately common condition among those with uncontrolled diabetes.

A gentle body massage is relaxing, and thus health-promoting. Add 40 times to the pressure, and the massage will become a form of physical torture; certainly unhealthy. That does not mean that a gentle body massage is unhealthy.

Interestingly, ketoacidosis often happens together with hyperglycemia, so at least part of the damage associated with ketoacidosis is likely to be caused by high blood sugar levels. Ketosis, on the other hand, is not associated with hyperglycemia.

Finally, if ketosis led to accelerated AGEing to the same extent as, or worse than, chronic hyperglycemia does, where is the long-term evidence?

Since the late 1800s people have been experimenting with ketosis-inducing diets, and documenting the results. The Inuit and other groups have adopted ketosis-inducing diets for much longer, although evolution via selection might have played a role in these cases.

No one seems to have lived to be 150 years of age, but where are the reports of conditions akin to those caused by chronic hyperglycemia among the many that went “banting” in a more strict way since the late 1800s?

The arctic explorer Vilhjalmur Stefansson, who is reported to have lived much of his adult life in ketosis, died in 1962, in his early 80s. After reading about his life, few would disagree that he lived a rough life, with long periods without access to medical care. I doubt that Stefansson would have lived that long if he had suffered from untreated diabetes.

Severe ketosis, to the point of large amounts of ketones being present in the urine, may not be a natural state in which our Paleolithic ancestors lived most of the time. In modern humans, even a 24 h water fast, during an already low carbohydrate diet, may not induce ketosis of this type. Milder ketosis states, with slightly elevated concentrations of ketones showing up in blood tests, can be achieved much more easily.

In conclusion, the notion that ketosis causes accelerated aging to the same extent as chronic hyperglycemia seems more like fiction than fact.

Reference:

De Grey, A. (2007). Ending aging: The rejuvenation breakthroughs that could reverse human aging in our lifetime. New York: NY: St. Martin’s Press.

Monday, May 28, 2018

Moderate alcohol consumption’s benefits: Blood flow or hormesis?


Moderate alcohol consumption has been found again and again to be beneficial to health (, , ). Even somewhat pessimistic studies linking alcohol consumption with health suggest that 6 drinks per week is optimal (). One drink is generally defined as: a 4-ounce glass of wine, a 12-ounce bottle or can of beer, or a 1.5-ounce shot of hard liquor. The amounts of ethanol vary, with more in hard liquor: 4 ounces of wine = 10.8 g of ethanol, 12 ounces of beer = 13.2 g of ethanol, and 1.5 ounces of spirits = 15.1 g of ethanol.

Contrary to popular belief, the positive health effects of moderate alcohol consumption have little, if anything, to do with polyphenols such as resveratrol. It is in fact the ethanol content that leads to the positive effects, apparently reducing the incidence of coronary heart disease, diabetes, hypertension, congestive heart failure, stroke, dementia, Raynaud’s phenomenon, and all-cause mortality. Raynaud's phenomenon is associated with poor circulation in the extremities (e.g., toes, fingers), which in some cases can progress to gangrene.

Two main explanations for the positive health effects of moderate alcohol consumption are: (a) that it improves blood flow; and (b) that it improves liver function via hormesis. These two explanations are not mutually exclusive and may both be right. The latter explanation is based on the assumption that often a favorable biological response results from low exposures to toxins and other stressors. This is fundamentally a compensatory adaptation response ().

It is not very easy to find evidence in favor of the first explanation above – that moderate alcohol consumption improves blood flow. An old study by Fewings and colleagues is a welcome exception. The study was published in 1966 in the British Journal of Pharmacology. It is titled: “The effects of ethyl alcohol on the blood vessels of the hand and forearm in man” ().

The figure below, from the study, shows average measures for 5 people who consumed 100 ml of brandy. This is equivalent to about 2 drinks. Each set of points reflects measurements taken at 30-minute intervals. The top graph shows the variation in blood alcohol content over time in mg / 100 ml. The middle graph shows the variation in hand blood flow over time in what the authors reported to be ml / 100 ml / min. The bottom graph shows the variation in forearm blood flow over time in the same scale as hand blood flow.



Many other measures are reported by the authors of the study, including measures in response to direct intra-arterial injection of ethanol. When injected, ethanol appears to have a nonlinear effect, opposite to that of oral consumption at first. Injected ethanol seems to impair blood flow at first, and then improve it significantly after a while.

Oral ethanol intake, through drinking alcoholic beverages, is the main focus of this post.

The authors also show evidence that the improvement in blood flow maintains itself for more than 2 h, and that flow becomes impaired at very high levels of blood alcohol.

So, as we can see, moderate alcohol consumption seems to improve blood flow. Why would this enhance one’s health?

One reason is that many important chemicals flow through the blood, which is about 90 percent water. Among these chemicals are free fatty acids, glucose, vitamins, minerals and oxygen. Without these chemicals, organs cannot operate properly, and in fact their tissues may die rather quickly. For example, for normal function the brain requires 3.3 ml / min of oxygen per 100 g of brain mass.

Another reason is that impaired blood flow seems to be significantly associated with accelerated atherosclerotic plaque growth, via a phenomenon known as endothelial cell apoptosis ().

Wednesday, April 25, 2018

Alcohol consumption, mortality, and cardiovascular disease


The graphs below summarize key results from a study published in April of 2018 by the highly influential journal The Lancet (). The study reported having included at least 599,912 drinkers in the analysis and having recorded 40,310 deaths and 39,018 cardiovascular disease events. The authors of the study concluded that “For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk around or below 100 g per week.



The study was presented as being somewhat pessimistic: one cannot drink as much as previous data suggested. Let’s see. Two drinks of a spirit (e.g., whiskey) served “neat” (i.e., with nothing added to it) will typically add up to about 84 g; or 3 oz. If the alcohol content is 40 percent, such a double drink will contain about 33 g of alcohol. So, according to this study, you can still enjoy three double drinks of spirit per week, or six single drinks – which is almost one per day. That is not so little.

This study is consistent with most studies of the effect of alcohol consumption on health, which generally show results in terms of averages within fixed ranges of consumption. For example, they will show average mortality risks for people consuming 1, 2, 3 etc. drinks per day. These studies suggest that there is a J-curve relationship between alcohol consumption and health. That is, drinking a little is better than not drinking; and drinking a lot is worse than drinking a little.

Contrary to popular belief, the positive health effects of moderate alcohol consumption have little, if anything, to do with polyphenols such as resveratrol. Resveratrol, once believed to be the fountain of youth, is found in the skin of red grapes.

It is in fact the alcohol content that has positive effects, apparently reducing the incidence of coronary heart disease, diabetes, hypertension, congestive heart failure, stroke, dementia, Raynaud’s phenomenon, and all-cause mortality. Raynaud's phenomenon is associated with poor circulation in the extremities (e.g., toes, fingers), which in some cases can progress to gangrene.

In most studies of the effects of alcohol consumption on health, the J-curves emerge from visual inspection of the plots of averages across ranges of consumption. Rarely you find studies where nonlinear relationships are “discovered” by software tools such as WarpPLS (), with effects being adjusted accordingly.

Still, this study is indeed consistent with some past studies suggesting that the amount of alcohol intake that is optimal maybe less than most of us think ().

Monday, January 30, 2017

Blood glucose variations in normal individuals: A chaotic mess

I love statistics. But statistics is the science that will tell you that each person in a group of 20 people ate half a chicken per week over six months, until you realize that 10 died because they ate nothing while the other 10 ate a full chicken every week.

Statistics is the science that will tell you that there is an “association” between these two variables: my weight from 1 to 20 years of age, and the price of gasoline during that period. These two variables are indeed highly correlated, by neither has influenced the other in any way.

This is why I often like to see the underlying numbers when I am told that such and such health measure on average is this or that, or that this or that disease is associated with elevated consumption of whatever. Statistical results must be interpreted carefully. Lying with statistics is very easy.

A case in point is that of blood glucose variations among normal individuals. Try plotting them on graphs. What do you see? A chaotic mess, even when the individuals are pre-screened to exclude anybody with blood glucose abnormalities that would even hint at pre-diabetes. You see wild fluctuations that, while not going up to levels like 200 mg/dl, are much less predictable than many people are told they should be.

Blood glucose levels are influenced by so many factors (Elliott & Elliott, 2009) that I would be surprised if they were as smooth as those in graphs that are frequently used to show how blood glucose is supposed to vary in healthy individuals. Often we see a flat line up until the time of a meal, when the line curves up rapidly and then goes down quickly. It usually peaks at around 140 mg/dl, dropping well below 120 mg/dl after 2 hours.

Those smooth graphs are usually obtained through algorithms that have statistical methods at their core. The algorithms are designed to generate a smooth representations of scattered or disorganized data points. A little bit like the algorithms in software tools that plot best-fit regression curves passing through scattered points (e.g., warppls.com).

The picture below (click on it to enlarge) is from a 2006 symposium presentation by Prof. J.S. Christiansen, who is a widely cited diabetes researcher. The whole presentation is available from: www.diabetes-symposium.org. It shows the blood glucose variations of 21 young and normal individuals, based on data collected over a period of 2 days. Each individual is represented by a different color. The points on each curve are actually averages of two blood glucose measurements; the original measurements themselves vary even more chaotically.


As you can see from the picture above, each individual has a unique set of responses to main meals, which are represented by the three main blood glucose peaks. Overall, blood glucose levels vary from about 50 to 170 mg/dl, and in several cases remain above 120 mg/dl after 2 hours since a large meal. They vary somewhat chaotically during the night as well, often getting up to around 110 mg/dl.

And these are only 21 individuals, not 100 or 1000. Again, these individuals were all normal (i.e., normoglycemic, in medical research parlance), with an average glycated hemoglobin (HbA1c) of 5 percent, and a range of variation of HbA1c of 4.3 to 5.4 percent.

We can safely assume that these individuals were not on a low carbohydrate diet. The spikes in blood glucose after meals suggest that they were eating foods loaded with refined carbohydrates and/or sugars, particularly for breakfast. So, we can also safely assume that they were somewhat "desensitized" (in terms of glucose response) to those types of foods. Someone who had been on a low carbohydrate diet for a while, and who would thus be more sensitive, would have had even wilder blood glucose variations in response to the same meals.

Many people measure their glucose levels throughout the day with portable glucometers, and quite a few are likely to self-diagnose as pre-diabetics when they see something that they think is a “red flag”. Examples are a blood glucose level peaking at 165 mg/dl, or remaining above 120 mg/dl after 2 hours passed since a meal. Another example is a level of 110 mg/dl when they wake up very early to go to work, after several hours of fasting.

As you can see from the picture above, these “red flag” events do occur in young normoglycemic individuals.

If seeing “red flags” helps people remove refined carbohydrates and sugars from their diet, then fine.

But it may also cause them unnecessary chronic stress, and stress can kill.

Reference:

Elliott, W.H., & Elliott, D.C. (2009). Biochemistry and molecular biology. 4th Edition. New York: NY: Oxford University Press.

Monday, February 23, 2015

What is the probability that you are NOT diabetic if your fasting blood glucose is 110-126 mg/dl?


Often I hear from readers who have changed their diets and lifestyles toward a more evolutionarily sound direction () that their fasting blood glucose (FBG) readings have gone up. Frequently numbers in the range 110-126 mg/dl (6.1-7 mmol/l) are mentioned.

If you have a FBG reading of 110-126 mg/dl (6.1-7 mmol/l) very likely your doctor will tell you that you are either diabetic or well on your way be becoming diabetic.

Diabetes is a condition that in humans is most frequently associated with damage to the beta cells in the pancreas, significantly impairing insulin secretion. With limited insulin, glucose levels tend to go up, leading to high FBG levels and high glucose peaks after consumption of carbohydrates. The latter, high glucose peaks, appear to be particularly damaging when happening regularly over time.

What is the probability that you are NOT diabetic with this FBG reading?

I put together the table below, based on data from a widely cited meta-analysis () conducted by the research group called The Emerging Risk Factors Collaboration. It shows the distribution of FBG levels in urban settings among individuals who do not have diabetes.



The numbers in this table are fairly consistent with those from various other surveys of large numbers of individuals in urban settings.

The study mentioned above also tells us that the incidence of diabetes in urban populations is in the neighborhood of 6.8 percent. This may not sound like much, but as disease incidences goes, it is very high – approximately 1 in every randomly selected group of 15 people has diabetes.

The vast majority of those diagnosed will have diabetes mellitus type 2, which tends to develop over time and be associated with the metabolic syndrome ().

We know from Bayes' theorem, which is a fundamental element of the increasingly popular Bayesian statistics, that the probability of an event A given that an event B has occurred [denoted P(A|B)] is given by:

P(A|B)=P(B|A)*P(A)/P(B).

In the equation above, P(B|A) is the probability of event B given A, P(A) is the probability of event A, and P(B) is the probability of event B.

To answer the question posed in the title of this blog post, we need to calculate the probability that a person will have no diabetes given that he or she has a fasting blood glucose of 110-126 mg/dl.

Replacing A and B in the equation above with “NoDiabetes” (short for not having diabetes) and “FBG=110-126 mg/dl” respectively, we arrive at the formula to calculate the probability that answers the question:

P(NoDiabetes|FBG=110-126 mg/dl)=P(FBG=110-126 mg/dl|NoDiabetes)*P(NoDiabetes)/P(FBG=110-126 mg/dl).

From the table above we know that P(FBG=110-126 mg/dl|NoDiabetes)=7 percent. From our previous discussion, we know that P(NoDiabetes)=(100-6.8)/100 =93.2 percent.

Finally, the study tells us that P(FBG=110-126 mg/dl) is 9.1 percent. This includes individuals with diabetes (2.1 percent) and without diabetes (7 percent).

With these numbers, we can calculate the probability that a person will have no diabetes given that he or she has a FBG of 110-126 mg/dl:

P(NoDiabetes|FBG=110-126 mg/dl)=0.07*(1-0.068)/0.091=0.72.

That is, if your fasting blood glucose is in the 110-126 mg/dl range (6.1-7 mmol/l) then the probability that you DO NOT have diabetes is 72 percent. It would be much safer to bet that you do not have diabetes than that you do, even at that relatively high range.

Surprising eh!?

The above discussion not only highlights the lack of reliability of fasting blood glucose levels for diabetes diagnoses in the 110-126 mg/dl range (6.1-7 mmol/l), but also begs the question – what could cause high fasting blood glucose levels in healthy individuals?

Some of the folks I heard from have gone through insulin sensitivity tests (see, e.g., ), and were found to be insulin sensitive (in at least one case, highly sensitive), even though their baseline glucose levels are generally high. This goes against the possible speculation that they are prediabetics well on their way to becoming diabetic.

One possibility has been discussed in a previous post, which also mentions what could happen with HbA1c levels ().

Monday, August 11, 2014

Slow versus slow-brisk walking: Effects on type 2 diabetics


I am not a big fan of reviewing new studies published in refereed journals, particularly those that make it to the news. I prefer studies that have been published for a while, so that I can look at citations to them – both positive and negative.

But I am making an exception here to a study by Kristian Karstoft and colleagues (the senior author is diabetes researcher Thomas Solomon: ), accepted for publication on 30 June 2014 in the fairly targeted and selective journal Diabetologia (full text freely available in a .zip file at the time of this writing: ).

This is a small study. Individuals diagnosed with type 2 diabetes, and who were not being treated for the condition, were allocated to three groups: a control group (CON), an “interval” walking group (IWT), and a slow walking group (CWT).

The groups had 8, 12, and 12 people in them, respectively. Those people in the IWT group alternated between walking briskly and slowly for 1 hour five times a week. Those in the CWT group only walked slowly. Those in the CON group supposedly did not do any targeted exercise.

One of the interesting findings of this study was that there was no difference in terms of health effects between the CWT and the CON groups. The only group that benefited was the IWT group. That is, those who alternated between walking briskly and slowly benefited in a way that was observable from the exercise, but those who walked slowly did not.

This study highlights two facts that I have mentioned here before, but that are often overlooked by those who suffer from type 2 diabetes or are on their way to developing the condition. They refer to visceral fat and are listed below. Visceral fat accumulates around the abdominal organs ().

- Type 2 diabetes is strongly associated with visceral fat accumulation, and is somewhat unrelated to subcutaneous fat accumulation (see the case of sumo wrestlers: ).

- Visceral fat is very easy to burn via glycolytic exercise, but does not seem to respond well to non-glycolytic exercise.

Glycolytic exercise burns sugar stored in muscle, in the form of glycogen, while it is being performed. This form of exercise raises growth hormone levels acutely. Weight training and sprints are types of glycolytic exercise, which also takes other names, such as glycogen-depleting and anaerobic exercise.

Often one sees prediabetics and type 2 diabetics avoiding this type of exercise because it pushes their blood glucose levels through the roof. That happens, however, only during the exercise. After, the benefits are tremendous and appear to clearly outweigh the possible problems associated with the temporary exercise-induced hyperglycemia.

Take a look at the last line of this cropped version of Table 1 from the study, shown below. The relevant line for the point made above is the one that refers to visceral fat volume. As you can see, those in the IWT group had the greatest reduction in visceral fat. This was also the only statistically significant reduction among the three groups; according to an analysis of variance (ANOVA) test, the probability that it was due to chance was lower than one tenth of one percent.



The ANOVA test is "parametric", in the sense that it assumes that the data is normally distributed. However, the authors did not report conducting a test of normality. Also, the sample is very small. Given these, "non-parametric" tests, such as multiple one-group-two-conditions tests run with WarpPLS (link to specific page of the .pdf file of a relevant academic paper: ) would not only be more advisable but also provide more much more information to readers.

If you compare the line showing visceral fat with the other two above it, within the body composition section of the table, you will notice another interesting pattern. In the IWT group the changes in average total body mass and total fat mass were also the greatest, but the largest change in percentage terms was the one in average visceral fat mass. Visceral fat mass is often correlated with total fat mass, with this correlation being a function of how sedentary individuals are, and it does not take a lot of it to cause serious problems.

Sumo wrestlers tend to have large ratios of total to visceral fat mass. Virtually all of their body fat is subcutaneous. They also carry a lot of muscle mass. They achieve these through intense glycolytic exercise alternated with periods of rest and consumption of large amounts of calorie-dense food. To these they add another ingredient - exercise in the fasted state, usually in the morning prior to a large breakfast. Exercise in the fasted state seems particularly conducive to visceral fat mobilization.

By the way, sumo wrestlers consume enormous amounts of carbohydrates, but as noted by Karam () have "low visceral fat, absent hyperglycemia and absent dyslipidemia despite massive subcutaneous obesity".

In my opinion the folks in the study by Karstoft and colleagues would have benefited even more, possibly a lot more, if they had alternated between sprinting and regular walking.

Wednesday, March 5, 2014

Can intermittent very-low-calorie dieting cure diabetes?


The health effects of very-low-calorie diets (VLCDs) adopted for short periods of time (e.g., 5 days) have been the target of much recent in the past. Consuming 400-600 kcal/day would be considered VLCDing. VLCDing for significantly longer periods of time than 5 days can be dangerous, and in some cases potentially fatal. Nevertheless, there is speculation that it can also cure type II diabetes ().

Intermittent VLCDs mimic in part what probably happened with our ancestors in our evolutionary past. Successful hunting and gathering would lead to weight-maintenance food intake most of the time, with occasional periods of severe food scarcity. This has probably been a regular pattern in our evolutionary history, leading to health-promoting adaptations that are triggered by VLCDs.

The part that VLCDs alone do not mimic is the “hunting and gathering part”, or the exercise required to obtain food when it is scarce. This is an important point, because VLCDs are likely to induce lean body mass loss without exercise, together with body fat loss. VLCDs without exercise are not very natural, even though they can have very positive effects on one’s health, as we’ll see below.

An interesting and well cited study of the effects of VLCDs in participants with type II diabetes was published in 1998 in an article authored by Katherine V. Williams and colleagues (). The study included 54 participants, and lasted 20 weeks in total. The site of the study was the University of Pittsburgh School of Medicine. The participants were split in three groups, referred to as:

- Standard behavioral therapy (SBT). The participants received a 1,500−1,800 kcal/day diet throughout, with the goal of inducing gradual weight loss.

- Intermittent 1 day/week VLCD (one-day). The participants received a VLCD for 5 consecutive days during week 2, followed by an intermittent VLCD therapy for 1 day/week for 15 weeks, with a 1,500−1,800 kcal/day diet at other times.

- Intermittent 5 day/week VLCD (five-day). The participants received a VLCD for 5 consecutive days during week 2, followed by an intermittent VLCD therapy for 5 consecutive days every 5 weeks (5-day), with a 1,500−1,800 kcal/day diet at other times.

There is a reason behind this complicated arrangement. The researchers wanted to make sure that the average caloric intake for the two VLCD groups was identical, but 18,000-28,000 kcal lower than for the SBT group. The SBT group served as a baseline group.

All of the three diets were designed to make the participants lose weight. Exercise was not manipulated as part of the experiment. The one-day and five-day groups consumed 400-600 kcal/day while VLCDing, with the majority of the calories coming from high-protein-low-fat minimally processed food items – notably lean meat, fish, and fowl.

The graphs below show results in terms of weight loss and fasting plasma glucose (FPG) reduction. They suggest that, while there were significant differences in weight loss between the VLCD groups and the SBT group, the differences in FPG reduction were relatively minor across the three groups.





Glucose was measured in mmol/l and weight in kg. One mmol/l is equivalent to approximately 18 mg/dl (), and one kg is equivalent to about 2.2 lbs.

The graph below, however, shows a different picture. It shows results in terms of the percentages of participants with HbA1c below 6 percent. The HbA1c is a measure of average blood glucose over a period of a few months ().



The graph above tells us that the intermittent VLCD interventions, particularly the second (five-day), were reasonably successful at promoting average blood glucose control. A threshold normally used to characterize poor blood glucose control is 7.3 percent (), which is based on studies of HbA1c levels associated with diabetes complications.

The graph below, which is probably the most telling of all, shows long-term FPG changes (at the 20-week mark) plotted against short-term changes (at the 3-week mark). What this graph tells us is that those who experienced the most improvement right away were the ones with the most improvement in the long term.



This study tells us a few interesting things. Firstly, intermittent VLCDing with a focus on high-protein foods (lean meats) seems to be a powerful way of controlling average blood glucose levels in diabetics. It is essentially a low carbohydrate diet that is also low in calories (). Secondly, results with respect to FPG levels are not as telling as those in terms of HbA1c levels, even though HbA1c and FPG are highly correlated.

Thirdly, intermittent VLCDing may not actually “cure” diabetes when significant beta cell damage has already occurred (). This conclusion is speculative, but it follows from the short-term versus long-term results.

It seems that intermittent VLCDing helps diabetics in general with glucose control, but is truly curative for those in which enough beta cell function has been preserved. At least this is one explanation for the fact that those with immediate positive results (at the 3-week mark) tend to be the ones who retain those results over the long term.

The immediate positive results may well be due to those individuals not having reached the point at which significant and irreversible beta cell damage occurred. In other words, this study suggests that intermittent VLCDing can be particularly helpful in the long term for prediabetics.

This third, and speculative, conclusion may have to be revisited in light of the excellent discussion by Roy Taylor on the etiology and reversibility of type II diabetes (), linked by Evelyn (see comments under this post). This refers to the effects of an extended and more extreme version of VLCD than discussed here, where uninterrupted VLCD would last as long as 8 weeks.

For those who are not diabetic, I personally think it would be better to alternate VLCD with glycogen depleting exercise (e.g., sprints, weight training), every other day or so, with a lot more food consumed on exercise days (). After excess body fat is lost, it would be advisable to stick to weight-maintenance calorie intake, averaged over a week.

Monday, March 25, 2013

Drs. Francisco Cervantes and Marivic Torregosa, and the 2013 Ancestral Health Symposium


Last year I traveled to South Korea to give presentations on nonlinear structural equation modeling and WarpPLS (). These are an advanced statistical analysis technique and related software tool, respectively, which have been used extensively in this blog to analyze health data, notably data related to the China Study.

I gave a couple of presentations at Korea University, which is in Seoul, and a keynote address at a conference in Gwangju, in the south part of the country. So I ended up seeing quite a lot of this beautiful country, and meeting many people. Some of my impressions regarding health and lifestyle issues need separate blog posts, which are forthcoming.

One issue that kept me thinking, as it did when I visited Japan a few years ago as well, was the obvious leanness of the South Koreans, compared with Americans, even though you don’t see a lot of emphasis on dieting there. Interestingly, this phenomenon also poses a challenge to many dietary schools of thought. For example, consumption of high-glycemic-index carbohydrates seems to be relatively high in South Korea.

The relative leanness of South Koreans is probably due to a combination of factors. A major one, it seems, is often forgotten. It is related to epigenetics. This term, “epigenetics”, is often assigned different meanings depending on the context in which it is used. Here it is used to refer to innate predispositions that don’t have a primarily genetic basis ().

Epigenetic phenomena often give the impression that acquired characteristics can be inherited, and are frequently, and misguidedly, used as examples in support of a theory often associated with Jean-Baptiste Pierre Antoine de Monet, better known as Lamarck.

A classic example of epigenetics, in this context, is that of a mother with type II diabetes giving birth to a child that will develop type II diabetes at a young age. Typically type II diabetes develops in adults, but its incidence in children has been increasing lately, particularly in certain areas. And I think that this classic example is in part related to the general leanness of South Koreans and of people in other cultures where adoption of highly industrialized foods has been relatively slow.

In other words, I think that it is possible that a major protection in South Korea, as well as in Japan and other countries, is the cultural resistance, particularly among older generations, against adopting modern diets and lifestyles that deviate from their traditional ones.

This brings me to Drs. Francisco Cervantes and Marivic Torregosa (pictured below). Dr. Cervantes is the Chief Director of Laredo Pediatrics and Neonatology, a pediatrician who studied and practiced in a variety of places, including Mexico, New Jersey, and Texas. Dr. Torregosa is a colleague of mine, a college professor and nurse practitioner in Laredo, with a Ph.D. in nursing and a research interest in child obesity.



As it turns out, Laredo, a city in Southwestern Texas near the border with Mexico, seems like the opposite of South Korea in terms of health, and this may well be related to epigenetics. This presents an enormous opportunity for research, and for helping people who really need help.

In Laredo, as well as in other areas where insulin resistance and type II diabetes are rampant, there is a great deal of variation in health. There are very healthy folks in Laredo, and very sick ones. This great deal of variation is very useful in the identification of causative factors through advanced statistical analyses. Lack of variation tends to have the opposite effect, often “hiding” causative effects.

Drs. Cervantes, Torregosa, and I had a presentation accepted for the 2013 Ancestral Health Symposium, organized by the Ancestral Health Socienty (). It is titled “Gallbladder Disease in Children: Separating Myths from Facts”. It is entirely based on data collected and analyzed by Dr. Cervantes, who is very knowledgeable about statistics. Below is the abstract.

Cholesterol’s main role in the body is to serve as raw material for bile acids; the conversion of cholesterol to bile acids by the liver accounts for approximately 70 percent of the daily disposal of cholesterol. Bile acids are then stored in the gallbladder and secreted to aid in the digestion of dietary fat. It is often believed that high cholesterol levels cause gallbladder disease. In this presentation, we will discuss various aspects of gallbladder disease, with a focus on children. The presentation will be based on data from 2116 patients of the Laredo Pediatrics & Neonatology. The patients, 1041 boys and 1075 girls, are largely first generation American-born children of Hispanic descent; a group at very high risk of developing gallbladder disease. This presentation will dispel several myths, and lay out a case for a strong association between gallbladder disease and abnormally high body fat levels. Gallbladder disease appears to be largely preventable in children through diet and lifestyle modifications, some of which will be discussed during the presentation.

Many people seem to be unaware of the fact that cholesterol production and disposal are strongly associated with secretion of bile acids. Most of the body's cholesterol is used to produce bile acids, which are reabsorbed from the gut, in a cyclical process. This is the reason behind the use of "bile acid sequestrants" to reduce cholesterol levels.

The focus on gallbladder disease in the presentation comes from an interest by Dr. Cervantes, based on his many years of clinical experience, in using gallbladder disease markers to identify and prevent other conditions, including several conditions associated with what we refer to as diseases of affluence or civilization.

Dr. Cervantes is unique among clinical practitioners in that he spends a lot of time analyzing data from his patients. His knowledge of data analyses techniques rivals that of many professional researchers I know. And he does that at his own expense, something that most clinical practitioners are unwilling to do. Dr. Cervantes and I will be co-authoring blog posts here in the future.

Monday, March 11, 2013

The 2013 PLoS ONE sugar and diabetes study: Sugar from fruits is harmless


A new study linking sugar consumption with diabetes prevalence has gained significant media attention recently. The study was published in February 2013 in the journal PLoS ONE (). The authors are Sanjay Basu, Paula Yoffe, Nancy Hills and Robert H. Lustig.

Among the claims made by the media is that “… sugar consumption — independent of obesity — is a major factor behind the recent global pandemic of type 2 diabetes” (). As it turns out, the effects revealed by the study seem to be very small, which may actually be a side effect of data aggregation; I will discuss this further below.

Fruits are exonerated

Let me start by saying that this study also included in the analysis the main natural source of sugar, fruit, as a competing variable (competing with the effects of sugar itself), and found it to be unrelated to diabetes. As the authors note: “None of the other food categories — including fiber-containing foods (pulses, nuts, vegetables, roots, tubers), fruits, meats, cereals, and oils — had a significant association with diabetes prevalence rates”.

This should not surprise anyone who has actually met and talked with Dr. Lustig, the senior author of the study and a very accessible man who has been reaching out to the public in a way that few in his position do. He is a clinician and senior researcher affiliated with a major university; public outreach, in the highly visible way that he does it, is probably something that he does primarily (if not solely) to help people. Dr. Lustig was at the 2012 Ancestral Health Symposium, and he told me, and anyone who asked him, that sugar in industrialized foods was his target, not sugar in fruits.

As I noted here before, the sugar combination of fruits, in their natural package, may in fact be health-promoting (). The natural package probably promotes enough satiety to prevent overconsumption.

Both (unnatural) sugar and obesity have effects, but they are tiny in this study

The Diabetes Report Card 2012 () provides a wealth of information that can be useful as a background for our discussion here.

In the USA, general diabetes prevalence varies depending on state, with some states having higher prevalence than others. The vast majority of diabetes cases are of type 2 diabetes, which is widely believed to be strongly associated with obesity.

In 2012, the diabetes prevalence among adults (aged 20 years or older) in Texas was 9.8 percent. This rate is relatively high compared to other states, although lower than in some. So, among a random group of 1,000 adult Texans, you would find approximately 98 with diabetes.

Prevalence increases with age. Among USA adults in general, prevalence of diabetes is 2.6 percent within ages 20–44, 11.7 percent within ages 45–64, and 18.9 percent at age 64 or older. So the numbers above for Texas, and prevalence in almost any population, are also a reflection of age distribution in the population.

According to the 2013 study published in PLoS ONE, a 1 percent increase in obesity prevalence is associated with a 0.081 percent increase in diabetes prevalence. This comes directly from the table below, fifth column on the right. That is the column for the model that includes all of the variables listed on the left.



We can translate the findings above in more meaningful terms by referring to hypothetical groups of 1,000 people. Let us say we have two groups of 1,000 people. In one of them we have 200 obese people (20 percent); and no obese person in the other. We would find only between 1 and 2 people with diabetes in the group with 200 obese people.

The authors also considered overweight prevalence as a cause of diabetes prevalence. A section of the table with the corresponding results in included below. They also found a significant effect, of smaller size than for obesity – which itself is a small effect.



The study also suggests that consumption of the sugar equivalent of a 12 oz. can of regular soft drink per person per day was associated with a 1.1 percent rise in diabetes prevalence. The effect here is about the same as that of a 1 percent increase in obesity.

That is, let us say we have two groups of 1,000 people. In one of them we have 200 people (20 percent) consuming one 12 oz. can of soft drink per day; and no one consuming sugar in the other. (Sugar from fruits is not considered here.) We would find only about 2 people with diabetes in the group with 200 sugary soda drinkers.

In other words, the effects revealed by this study are very small. They are so small that their corresponding effect sizes make them borderline irrelevant for predictions at the individual level. Based on this study, obesity and sugar consumption combined would account for no more than 5 out of each 100 cases of diabetes (a generous estimate, based on the results discussed above).

Even being weak, the effects revealed by this study are not irrelevant for policy-making, because policies tend to influence the behavior of very large numbers of people. For example, if the number of people that could be influenced by policies to curb consumption of refined sugar were 100 million, the number of cases of diabetes that could be prevented would be 200 thousand, notwithstanding the weak effects revealed by this study.

Why are the effects so small?

The effects in this study are based on data aggregated by country. When data is aggregated by population, the level of variation in the data is reduced; sometimes dramatically, a problem that is proportional to the level of aggregation (e.g., the problem is greater for country aggregation than for city aggregation).

Because there can be no association without correlation, and no correlation without variation, coefficients of association tend to be reduced when data aggregation occurs. This is, in my view, the real problem behind what statisticians often refer to, in “statospeech”, as “ecological fallacy”. The effects in aggregated data are weaker than the effects one would get without aggregation.

So, I suspect that the effects in this study, which are fairly weak at the level of aggregation used (the country level), reflect much stronger effects at the individual level of analysis.

Bottom line

Should you avoid getting obese? Should you avoid consuming industrialized products with added sugar? I think so, and I would still have recommended these without this study. There seems to be no problem with natural foods containing sugar, such as fruits.

This study shows evidence that sugar in industrialized foods is associated with diabetes, independently from obesity, but it does not provide evidence that obesity doesn’t matter. It shows that both matter, independently of one another, which is an interesting finding that backs up Dr. Lustig’s calls for policies to specifically curb refined sugar consumption.

Again, what the study refers to as sugar, as availability but implying consumption, seems to refer mostly to industrialized foods where sugar was added to make them more enticing. Fruit consumption was also included in the study, and found to have no significant effect on diabetes prevalence.

Here is a more interesting question. If a group of people have a predisposition toward developing diabetes, due to any reason (genetic, epigenetic, environmental), what would be the probability that they would develop diabetes if they became obese and/or consumed unnatural sugar-added foods?

This type of question can be answered with a moderating effects analysis, but as I noted here before (), moderating effects analyses are not conducted in health research.